Werewolf Therapeutics, Inc. (HOWL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:05PM EDT. Market open.
| Previous close | 2.3500 |
| Open | 2.3200 |
| Bid | 2.1300 x 100 |
| Ask | 2.1600 x 100 |
| Day's range | 2.1000 - 2.3200 |
| 52-week range | 1.5740 - 8.1940 |
| Volume | |
| Avg. volume | 298,769 |
| Market cap | 92.995M |
| Beta (5Y monthly) | 0.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
All You Need to Know About Werewolf Therapeutics (HOWL) Rating Upgrade to Buy
Werewolf Therapeutics (HOWL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Zacks
How Much Upside is Left in Werewolf Therapeutics, Inc. (HOWL)? Wall Street Analysts Think 92.37%
The consensus price target hints at a 92.4% upside potential for Werewolf Therapeutics, Inc. (HOWL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- Simply Wall St.
Werewolf Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Werewolf Therapeutics ( NASDAQ:HOWL ) Full Year 2023 Results Key Financial Results Revenue: US$19.9m (up 22% from FY...
© 2024 Yahoo. All rights reserved.